doi: 10.1371/journal.pone.0244402 139 CroyalMSaulnierPJAguesseAGandERagotSRousselRet al
R.BrockwayJ
For tirzepatide at the highest dose, the SURMOUNT-1 trial showed an average of 22.5% weight loss at 72 weeks, which represents one of the most significant weight loss results ever achieved with any medication
doi: 10.3389/fped.2021.657020
But for the many people who struggle to lose weight, even while pursuing a healthier lifestyle, Anegawa recommends trying Motus, a naturally derived, science-backed product that burns fat, not muscle, and helps people keep it off for good.* A recent six-month human study found that participants on Motus experienced a 10.4% total body weight reduction, and 87% of the weight lost was fat mass, not lean mass
The pharmaceutical-grade glutathione, which is used in Vitadrip IV, is the same grade as that of hospital-grade IV preparations